Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment for Advanced Colorectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06380101
What this trial is testing

Evaluating a Nonessential Amino Acid Restriction (NEAAR) Medical Food With Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer (LARC)

Who this might be right for
Rectal Cancer
University of South Florida 30
Not applicableStudy completedNCT00040820
What this trial is testing

Oxaliplatin in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Roswell Park Cancer Institute
Early research (Phase 1)Not Yet RecruitingNCT07363408
What this trial is testing

Ivonescimab and ADG126, Alone, and in Combination With Leucovorin and Fluorouracil or FOLFIRI Regimen for the Treatment of Microsatellite Stable Advanced/Metastatic Colorectal Cancer

Who this might be right for
Advanced Microsatellite Stable Colorectal CarcinomaMetastatic Microsatellite Stable Colorectal CarcinomaStage III Colorectal Cancer AJCC v8+1 more
City of Hope Medical Center 30
Testing effectiveness (Phase 2)UnknownNCT05335460
What this trial is testing

To Determine the Efficacy and Safety of Envafolimab Combined With XELOX for Locally Advanced Colon Cancer

Who this might be right for
Colon Cancer
Fujian Cancer Hospital 36
Not applicableStudy completedNCT01691391
What this trial is testing

Early Biomarker With 18F-FDG PET for Treatment Optimization of Anti-EGFR Therapy in Patients With Metastatic Colorectal Cancer.

Who this might be right for
Colorectal Cancer
Amsterdam UMC, location VUmc 46
Not applicableEnded earlyNCT00896467
What this trial is testing

Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy

Who this might be right for
Anal CancerAnxiety DisorderBreast Cancer+9 more
Centre Oscar Lambret 200
Testing effectiveness (Phase 2)Study completedNCT00113230
What this trial is testing

Neoadjuvant Chemoradiation With RHUMAB VEGF (Avastin) for Rectal Cancer

Who this might be right for
Rectal Cancer
M.D. Anderson Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT00217711
What this trial is testing

Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

Who this might be right for
Colorectal Cancer
Swiss Cancer Institute 23
Large-scale testing (Phase 3)Not Yet RecruitingNCT03975049
What this trial is testing

Triplet Combination or Doublet Regimen Versus Chemoradiation as Neoadjuvant Therapy for Locally Advanced Rectal Cancer

Who this might be right for
Rectal CancerChemotherapy Effect
Sixth Affiliated Hospital, Sun Yat-sen University 933
Not applicableUnknownNCT05368051
What this trial is testing

Multi-omics Model Predicts Efficacy of Preoperative Neoadjuvant Chemoradiotherapy Combined PD-1 Antibody Therapy for Locally Advanced Rectal Cancer

Who this might be right for
Colorectal Neoplasms
Beijing Friendship Hospital 30
Testing effectiveness (Phase 2)UnknownNCT06575127
What this trial is testing

Modified FOLFOXIRI Plus Target Therapy as a First Line Treatment for Advanced Colorectal Cancer a Prospective Phase Two Study

Who this might be right for
Neoplasm MalignantColon Cancer Stage 4
Al-Azhar University 60
Testing effectiveness (Phase 2)Ended earlyNCT00611858
What this trial is testing

Cetuximab, 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Dana-Farber Cancer Institute 13
Large-scale testing (Phase 3)Study completedNCT00427713
What this trial is testing

Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal Cancer

Who this might be right for
Colorectal Cancer
Cancer Research UK 800
Large-scale testing (Phase 3)Ended earlyNCT00068744
What this trial is testing

Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer

Who this might be right for
Anal Cancer
European Organisation for Research and Treatment of Cancer - EORTC 88
Early research (Phase 1)Ended earlyNCT04926324
What this trial is testing

A Safety Study Adding Niraparib and Dostarlimab to Radiation Therapy for Rectal Cancers

Who this might be right for
Rectal NeoplasmsRectal Neoplasm Malignant
University of Iowa 3
Large-scale testing (Phase 3)Study completedNCT00975897
What this trial is testing

Study of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Medical Research Council 3,240
Early research (Phase 1)Study completedNCT00280176
What this trial is testing

Bortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal Cancer

Who this might be right for
Colorectal Cancer
UNC Lineberger Comprehensive Cancer Center 11
Testing effectiveness (Phase 2)UnknownNCT05575635
What this trial is testing

Neoadjuvant Treatment of Fruquintinib Combined With Concurrent Chemoradiotherapy for LARC

Who this might be right for
Rectal Cancer
Henan Provincial People's Hospital 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03840239
What this trial is testing

TNT to Increase the Clinical Complete Response Rate for Distal LARC

Who this might be right for
Rectal CancerRectal Cancer Stage IIRectal Cancer Stage III+1 more
Sun Yat-sen University 98
Testing effectiveness (Phase 2)Looking for participantsNCT06776757
What this trial is testing

Sintilimab in Combination with Cetuximab and Chemotherapy As First-line Treatment for RAS/BRAF Wild-type Advanced Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center 30
Next Page